- Home
- MCBS vs BVS Comparison
MCBS vs BVS Comparison
Compare MCBS & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MCBS | BVS |
|---|---|---|
| Founded | 2006 | 2011 |
| Country | United States | United States |
| Employees | N/A | 940 |
| Industry | Major Banks | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 816.1M | 716.8M |
| IPO Year | 2019 | 2016 |
Fundamental Metrics
Financial Performance| Metric | MCBS | BVS |
|---|---|---|
| Price | $31.78 | $10.62 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | ★ $33.00 | $14.00 |
| AVG Volume (30 Days) | 53.2K | ★ 426.4K |
| Earning Date | 04-24-2026 | 05-06-2026 |
| Dividend Yield | ★ 3.63% | N/A |
| EPS Growth | 4.76 | ★ 163.46 |
| EPS | ★ 0.77 | 0.04 |
| Revenue | N/A | ★ $568,087,000.00 |
| Revenue This Year | $36.78 | $7.52 |
| Revenue Next Year | $2.44 | $7.06 |
| P/E Ratio | ★ $40.53 | $264.25 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $24.53 | $5.81 |
| 52 Week High | $33.67 | $11.25 |
Technical Indicators
Market Signals| Indicator | MCBS | BVS |
|---|---|---|
| Relative Strength Index (RSI) | 55.02 | 61.00 |
| Support Level | $30.72 | $8.27 |
| Resistance Level | $33.38 | $11.00 |
| Average True Range (ATR) | 0.80 | 0.55 |
| MACD | -0.17 | -0.01 |
| Stochastic Oscillator | 40.77 | 66.20 |
Price Performance
Historical ComparisonAbout MCBS MetroCity Bankshares Inc.
MetroCity Bankshares Inc is a holding company of its subsidiary Metro City Bank. It provides commercial banking services such as consumer and commercial checking accounts, savings accounts, certificates of deposits, commercial and consumer loans, money transfers and a variety of other banking services. The banks generate revenue from interest income. Its customers include small business owners, professionals, consumers, and real estate developers.
About BVS Bioventus Inc.
Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.